Son güncelleme :
19/11/2024
kanser ilaç   Topotecan  
Enjeksiyon
Çözeltilerin stabilitesi Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Uygulama yöntemi Kaynaklar pdf
   Kimyasal yapı   

Ticari isim   Ticari isim     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acumil Meksika
Camtoop Meksika
Cantop Hindistan
Hycamtin Almanya, Amerika Birleşik Devletleri, Avustralya, Avusturya, Belçika, Birleşik Arap Emirlikleri, Brezilya, Büyük Britanya, Danimarka, Ekvador, Finlandiya, Fransa, Hollanda, İrlanda, İspanya, İsveç, İsviçre, İtalya, İzlanda, Japonya, Kanada, Kolombiya, Lüksemburg, Macaristan, Malezya, Mısır, Norveç, Polonya, Portekiz, Şili, Suudi Arabistan, Türkiye, Venezuela, Yunanistan
Oncotecan Ekvador, Kolombiya
Potactasol Almanya, Arjantin, Belçika, Norveç, Romanya
Tekan L Türkiye
Topodria Kolombiya
Topokebir Arjantin, Peru
Toposec Peru
Topotecan Almanya, Belçika, Büyük Britanya, İspanya, Kanada, Kolombiya, Norveç, Peru, Romanya
Topotel Mısır
Toranex Meksika
Tpopoxin Türkiye
Viatopin Macaristan
Kaynaklar   Enjeksiyon    Kaynaklar : Topotecan  
tip yayın
753 Laboratuar Topotecan (Topotecan Hospira®) - Summary of Product Characteristics
Hospira 2016
823 Dergi Patel K, Craig SB, McBride MG, Palepu NR.
Microbial inhibitory properties and stability of topotecan hydrochloride injection.
Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
1026 Dergi Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1075 Dergi Craig SB, Bhatt UH, Patel K.
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
J Pharm Biomed Anal 1997 ; 16: 199-205.
1274 Dergi Krämer I, Thiesen J.
Pharmazeutische aspekte von topotecan-infusionen.
TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
1423 Dergi Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1425 Dergi Krämer I, Thiesen J.
Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices.
J Oncol Pharm Practice 1999 ; 5: 75-82.
1662 Dergi Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1953 Dergi Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1976 Dergi Trissel LA, Xu QA.
Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Int J Pharm Compound 2005 ; 9, 3: 238-241.

  Mentions Légales